Trial shows specialist long COVID care may reduce fatigue
The STIMULATE-ICP clinical trial, the largest of its kind, found that specialist multidisciplinary care can help reduce fatigue in long COVID patients. The study involved over 1,100 participants across six NHS clinics in England.
Why it matters
These findings provide evidence-based support for the effectiveness of specialized long COVID services, which is crucial for public health policy and patient recovery.
by Michael Lucibella, University College London
edited by Lisa Lock , reviewed by Robert Egan
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Credit: George Milton from Pexels The largest clinical trial of long COVID care to date has found that specialist NHS long COVID services may help reduce fatigue, one of the condition's most common and disabling symptoms. The findings, published in Nature Medicine and led by researchers and clinicians from UCL and UCLH, come from the STIMULATE-ICP trial.
The study involved more than 1,100 people receiving care through six NHS long COVID clinics in England, making it the largest trial to evaluate different approaches to delivering long COVID care.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in